by Marie Simon, Paris Brain InstituteGraphical abstract. Credit: Molecular Therapy - Methods & Clinical Development (2024). DOI: 10.1016/j.omtm.2024.101248Metachromatic leukodystrophy is a rare ge
by Marie Simon, Paris Brain InstituteGraphical abstract. Credit: Molecular Therapy - Methods & Clinical Development (2024). DOI: 10.1016/j.omtm.2024.101248Metachromatic leukodystrophy is a rare ge
by The University of Hong KongCredit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad597A research team from the School of Biomedical Sciences, LKS Faculty of Medicine of the Unive
by The University of Hong KongCredit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad597A research team from the School of Biomedical Sciences, LKS Faculty of Medicine of the Unive
by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainIn recent years, the scientific community has seen a push for more findable, accessible, interoperable, and reus
by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainIn recent years, the scientific community has seen a push for more findable, accessible, interoperable, and reus
by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio
by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio
by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large
by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large
by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite
by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite
by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q
by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q
by University College LondonCredit: Pixabay/CC0 Public DomainPersistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study.In the st
by University College LondonCredit: Pixabay/CC0 Public DomainPersistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study.In the st
byUniversity of California - BerkeleyAn illustration of a brain cell in a person with Alzheimer's disease, showing the accumulation and clumping of tau proteins (blue squiggles) in the cytop
byUniversity of California - BerkeleyAn illustration of a brain cell in a person with Alzheimer's disease, showing the accumulation and clumping of tau proteins (blue squiggles) in the cytop
by Kylie A Steel, Clare MacMahon and Todd Pickering,The ConversationCredit: CC0 Public Domain"Look for the gap!" "Move into space!" "Who's free?"Sound familiar?
by Kylie A Steel, Clare MacMahon and Todd Pickering,The ConversationCredit: CC0 Public Domain"Look for the gap!" "Move into space!" "Who's free?"Sound familiar?
by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with
by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with